Kolexia
Pittion-Vouyovitch Sophie
Neurologie
Hôpital Central
Nancy, France
64 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose en plaques Sclérose Sclérose en plaques récurrente-rémittente Sclérose en plaques chronique progressive Sclérose latérale amyotrophique Fatigue Maladies démyélinisantes Leucoencéphalopathies Leucoencéphalopathie multifocale progressive

Industries

Novartis
36 collaboration(s)
Dernière en 2023
Merck-Serono
6 collaboration(s)
Dernière en 2022
Sanofi
6 collaboration(s)
Dernière en 2022
Alexion
4 collaboration(s)
Dernière en 2022

Dernières activités

Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study.
Journal of neurology   29 février 2024
Real-life evaluation of the 2017 McDonald criteria for relapsing-remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis.
Journal of neurology   31 août 2023
NeurofilMS: Serum Neurofilament-light Chain and Glial Fibrillary Acidic Proten (GFAP) Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis
Essai Clinique (CHU Nîmes)   03 mai 2023
Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteria.
Revue neurologique   28 septembre 2022
INESEP: The Role of Social and Territorial Inequalities in the Management and Prognosis of Multiple Sclerosis - Longitudinal Observational Study - INESEP
Essai Clinique (CHU Nancy)   19 août 2021
Clinical and radiological activity of secondary progressive multiple sclerosis in a population-based cohort.
European journal of neurology   18 mai 2021
Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course.
Journal of neurology   31 mars 2021
Effect of familial clustering in the genetic screening of 235 French ALS families.
Journal of neurology, neurosurgery, and psychiatry   06 janvier 2021
Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity.
Journal of neurology   02 juillet 2020
Double-blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate-to-severe relapses of multiple sclerosis.
Journal of clinical apheresis   05 mai 2020